Evidence map›Paper›PMID 40369371›Full record

ArticleInflammation2025

Nonstructural Protein 1 Mediates HMGB1 Release by Targeting Histone H1.0 After Respiratory Syncytial Virus Infection In Vivo and In Vitro.

Na Zhou, Siyi Che, Hui Zhai, Xiaohong Xie, Enmei Liu, Jun Xie

Abstract read
In one paragraph

Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Na Zhou *Department of Respiratory Medicine, Children'S Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, 400014, China.
Siyi Che *Department of Respiratory Medicine, Children'S Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, 400014, China.
Hui ZhaiDepartment of Respiratory Medicine, Children'S Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, 400014, China.
Xiaohong XieDepartment of Respiratory Medicine, Children'S Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, 400014, China.
Enmei LiuDepartment of Respiratory Medicine, Children'S Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, 400014, China. emliu186@126.com.
Jun XieDepartment of Respiratory Medicine, Children'S Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, 400014, China. cyxiejun@126.com.

Funding

Chongqing Postdoctoral Research Special Funding 2023CQBSHTB3148Science and Technology Research Program of Chongqing Municipal Education Commission KJQN202200406
6 · The paper itself

Abstract

High mobility group box-1 (HMGB1) is implicated in airway inflammation during the late phase of respiratory syncytial virus (RSV) infection. Despite its recognized role, the specific mechanism underlying its release post-RSV infection remains ambiguous. The nonstructural protein 1 (NS1) has been associated with interactions with numerous host proteins, affecting diverse physiological processes, and it is speculated to be involved in the release of HMGB1. We utilized an in vivo model of RSV-infected mice and an in vitro model of RSV-infected A549 and 16HBE cells to investigate the role of NS1 in promoting HMGB1 release. Small interfering RNA was employed to deplete NS1, while lentiviral vectors were used for NS1 overexpression. The interaction between NS1 and H1.0 was confirmed by immunofluorescence analysis, immunoprecipitation, GST pull-down assays, surface plasmon resonance analysis and in silico study. Our study revealed that silencing the NS1 gene reduced the levels of HMGB1 protein and suppressed airway inflammation during the late stage of RSV infection. Depletion of NS1 led to decreased levels of intracellular and extracellular HMGB1 in A549 and 16HBE cells, while over-expression of NS1 increased HMGB1 expression. Furthermore, NS1 and HMGB1 directly interacted with histone H1.0, as confirmed by GST pull-down, surface plasmon resonance and in silico analyses. Overexpression of NS1 disrupted the binding of HMGB1 to H1.0, while silencing of NS1 enhanced their interaction. The research findings indicate that NS1 interacts with H1.0, thereby inhibiting the binding of HMGB1 to H1.0. Consequently, this interaction results in the release of HMGB1 into both the cytoplasm and the extracellular space.

Indexed as

HistonesHMGB1 ProteinRespiratory Syncytial Virus InfectionsViral Nonstructural ProteinsA549 CellsAnimalsHumansMiceMice, Inbred BALB CRespiratory Syncytial VirusesHistonesHMGB1 ProteinHMGB1 protein, humanHMGB1 protein, mouseViral Nonstructural ProteinsHistone H1.0HMGB1Nonstructural protein 1RSV

Identifiers

PMID40369371
PMCPMC12596378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.